Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction

Chest

Volumn 117, Issue 2, 2000, Pages 314-320

  Sharma, Nagaraja D ^a   McCullough, Peter A ^a   Philbin, Edward F ^a   Weaver, W Douglas ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Congestive heart failure; Left ventricular thrombus; Systemic embolism

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DILATATION; HUMAN; INCIDENCE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOEMBOLISM; THROMBUS;

EID: 0033995213     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.2.314     Document Type: Article

References (26)

1. 1 Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22(Suppl A):6-13
2. 2 Gottdiener JS, Gay JS, Van Voorhees L, et al. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol 1983; 52:1281-1285
3. 3 Segal JP, Stapleton JF, McClellan JR, et al. Idiopathic cardiomyopathy: clinical features, prognosis and therapy. Curr Probl Cardiol 1978; 3:1-48
4. 4 Reeder GS, Tajik AJ, Seward JB. Left ventricular mural thrombus: two dimensional echocardiographic diagnosis. Mayo Clin Proc 1981; 45:82-86
5. 5 Al-Khadra AS, Salem DN, Rand WM, et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998; 31:749-753
6. 6 Williams JF Jr, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practical Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995; 26:1376-1398
7. 7 Laupacis A, Albers G, Dunn M, et al. Antithrombotic therapy in atrial fibrillation. Chest 1992; 102(Suppl):S426-S433
8. 8 Falk RH. A plea for a clinical trial of anticoagulation in dilated cardiomyopathy. Am J Cardiol 1990; 65:914-915
9. 9 Koniaris LS, Goldhaber SZ. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol 1998; 31:745-748
10. 10 Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction predicts stroke following myocardial infarction. N Engl J Med 1997; 336:251-257
11. 11 Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-530
12. 12 Cheng JW, Spinler SA. Should all patients with dilated cardiomyopathy receive chronic anticoagulation? Ann Pharmacother 1994; 28:604-609
13. 13 Wilensky RL, Jung SC. Thromboembolism in patients with decreased left ventricular function: incidence, risk, and treatment. J Cardiovasc Risk 1995; 2:91-96
14. 14 Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987; 60:1340-1355
15. 15 Ciaccheri M, Castelli G, Cecchi F, et al. Lack of correlation between intracavitary thrombosis detected by cross-sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br Heart J 1989; 62:26-29
16. 16 Fuster V, Halperin JL. Left ventricular thrombi and cerebral embolism. N Engl J Med 1989; 320:392-394
17. 17 Stevenson LW, Perloff JK. The dilated cardiomyopathies: clinical aspects. Cardiol Clin 1988; 6:197-218
18. 18 Stratton JR, Nemanich JW, Johannessen KA, et al. Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy. Circulation 1988; 78: 1388-1393
19. 19 Natterson PD, Stevenson WG, Saxon LA, et al. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995; 129:564-570
20. 20 Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992; 123:136-142
21. 21 Katz SD, Marantz PR, Biasucci L, et al. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J 1993; 126:141-146
22. 22 Spodick DH, Littmann D. Idiopathic myocardial hypertrophy. Am J Cardiol 1958; 1:610-623
23. 23 Dunkman WB, Johnson GR, Carson PE, et al. Incidence of thromboembolic events in congestive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation 1993; 87(6Suppl):VI94-VI101
24. 24 Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327:669-677
25. 25 Dries DL, Rosenberg Y, Waclawiw M, et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29:1074-1080
26. 26 Kalaria VG, Passannante MR, Shah T, et al. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J 1998; 135:215-220